StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Cost of sales — Total by Year

Cost of sales — Total ($M) ($M)

Vertex Pharmaceuticals Cost of sales — Total: $1,651M in FY2025, up 7.9% from a year earlier. That is the highest of the 16 years on record here.

Latest, FY2025
1,651
Period ended Dec 31, 2025
Change on a year earlier
+7.9%
1,531 in FY2024
History
16 years
Since FY2010
Sources
13
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations & Segment Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCost of sales — Total ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,651+7.9%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20241,531+21.3%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20231,262+16.8%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 20221,080+19.5%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 2021904+22.8%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 2020736+34.4%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 2019548+33.8%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 2018410+48.9%Form 10-K (filed 2021-02-11) ↗
FY2017Dec 31, 2017275+30.7%Form 10-K (filed 2020-02-13) ↗
FY2016Dec 31, 2016211+79.6%Form 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 2015117+195.2%Form 10-K (filed 2016-02-16) ↗
FY2014Dec 31, 201439.7-55.4%Form 10-K (filed 2015-02-13) ↗
FY2013Dec 31, 201389-62.4%Form 10-K (filed 2014-02-11) ↗
FY2012Dec 31, 2012237+272.2%Form 10-K (filed 2013-03-01) ↗
FY2011Dec 31, 201163.6–Form 10-K (filed 2012-02-22) ↗
FY2010Dec 31, 20100–Form 10-K (filed 2013-03-01) ↗

Breakdown

What makes up cost of sales — Total

Cite this data

StockData. (2026). Vertex Pharmaceuticals Cost of sales — Total ($M), annual FY2010–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/seg-cogs-tot

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.